Our Katy weight loss clinic develops individualized programs based on your medical history, lifestyle, goals, and metabolic health
She is an active researcher and an experienced science writer
Semaglutide is a GLP-1 receptor agonist that, for many patients, provides sufficient appetite control and weight loss support without needing the dual-agonist approach that tirzepatide offers
Many of them dont just target the GLP-1 hormone, but go beyond this
However, many people achieve excellent results at 8 mg, and the maximum dose isn't necessary or appropriate for everyone
At the suggestion of her endocrinologist, she started semaglutide in April 2022 and switched to tirzepatide after an insurance change, losing 41 pounds so far, and nearing her goal